India Infoline advises clients to 'buy' and 'sell' same shares at same time

India Infoline had issued two different recommendations on Punj Lloyd to its clients on the same day

Have you ever come in contact with someone who advises you to buy and sell the same thing at the same time? No, then welcome to the world of Indian retail brokerages. One such brokerage, India Infoline, has come out with two different reports on Punj Lloyd Ltd on the same day but with opposite recommendations.

Both the reports, whose copies are with Moneylife, were published on 31 May 2010. In one report, India Infoline wanted institutional investors to 'sell' (which according to its recommendation structure meant, "Absolute-stock expected to fall by more than 10% over a 1-year horizon") shares of Punj Lloyd. It also gave a 12-month target price of Rs97 or 29% lower than the current trading price of Rs137 as on 28th May.

On the other hand, India Infoline's second report, issued on the same date and on the same company for its private client group recommended to 'buy' Punj Lloyd shares with a target price of Rs158 as against the closing price at the end of 28th May of Rs137. There was no time frame or limit mentioned for the target price in this report. According to India Infoline's recommendations parameters mentioned in this report, a 'buy' meant absolute return of over +10% (no time frame or limit mentioned).

For its private client group, the brokerage advised: "With a robust order book, the company is well covered for the next couple of years. The company does not have any legacy orders remaining to be executed and Punj Lloyd is shifting projects from Simon Carves to the parent entity. We expect the company's PBT to witness 74% CAGR over FY09-12E. We reduce our target price to Rs158 per share from Rs198 per share earlier to reflect concerns on extended period of non-billing its client and slow execution rate. However the recent correction in the price provides room for upside, hence we recommend high-risk investors to take exposure in the stock."

When contacted, Harshad Apte, India Infoline's vice president for corporate communications, said, "Both these reports are in fact, targeted and sent to two separate set of customers and also both these recommendations are for differing time horizons. One of the recommendations (IIFL Private Client Group) is for the retail clients and carries a shorter time horizon while the other one is meant for institutional clients and is for a longer time horizon."

There is no period mentioned in the report for the private client group. However, it is assumed that all brokerages use 12 months as standard period for target price.

So, the question still remains as to why the brokerage wants one group of its clients to sell and other to buy Punj Lloyd shares? Maybe the brokerage-and its clients-knew better.

After Moneylife wrote about this case and also brought it to the attention of the Securities and Exchange Board of India (SEBI), the brokerage firm has come out with a press release clarifying the research calls made by different teams of the IIFL group. However, the company's stand does nothing to comfort the investors; in fact it should raise eyebrows higher.

India Infoline had published two reports on 31 May 2010. In one report, the firm wanted institutional investors to 'sell' shares of Punj Lloyd, with a 12-month target price of Rs97 or 29% lower than the then trading price of Rs137 as on 28th May. On the other hand, the second report issued on the same date recommended its private client group to 'buy' Punj Lloyd shares with a target price of Rs158. No time horizon was mentioned for the private client group report.

The company, in its response, has very conveniently stated that the IIFL group has two separate and distinct retail and institutional research teams that are separated by 'Chinese walls'. In today's world of finance, it isn't too difficult to see the irony in this idea. The Chinese wall concept is most commonly utilised in financial institutions with interests in both investment banking and brokerage operations. Its purpose is to provide a separation between the two, while allowing the company to engage in both activities without creating a conflict of interest. This wall is not a physical boundary, but rather an ethical one that financial institutions are expected to observe.

While this was widely practised until a few years ago, wide cracks have become increasingly evident in the Chinese wall model over the years. The porous nature of this so-called wall was in full display during the recent debacle in Wall Street, when investment banks tumbled one after the other. These institutions are supposed to have internal policies that necessitate impartiality on the part of analysts. But very often, these policies are based on flimsy structures, open to being twisted and violated in the process. These institutions compensate the very same 'impartial' analysts based on some investment banking deals they might have participated in. The end result is there for all to see.

The case is no different in India where insider trading and market manipulation are rampant. Fancy portfolio management services (PMS) products offered by various brokerages show that there are, in effect, no Chinese walls. Moneylife has written about cases where PMS money has dramatically shrunk because the broking arm took the money heavily traded in and out of stocks that not only meant huge costs but also huge losses. These products are designed in such a way as to entice high net-worth individuals (HNIs), but are usually based on shoddy strategies that end up creating havoc on the client's portfolio. Very often, the advice to HNIs is diametrically opposite to that given to retail investors.

India Infoline's press release also states, "The respective research teams conduct independent research and reports are made by separate research analysts considering the various factors including client group to which they are providing the services, risk profile, investment goals, horizon of investment etc. Since the different sets of investors, institutional and non-institutional customers, have different time horizons and different investment philosophy, they need to be serviced differently." This looks good only on paper. Besides, we are not even sure if this is what the reality is. Indeed, SEBI is now thinking of actually removing Chinese walls inside asset management companies because they actually serve no purpose. 



Pradip Kumar Daftari

6 years ago

All brokerages, experts and analysts are in business and everyone should understand that they have vested interests in everything they do. Investors should educate themselves, and take informed decisions rather than going after any recommendations.In fact, they flourish on this kind of business.

Paresh Jani

6 years ago

If it is a true story then retail investors should be very catious while dealing with their brokers or sub brokers.

Weekly Market View: Biding Time

The market is about to make a major move but is not clear now in which direction

The market was down at the beginning of the week on weak global cues on concerns over the debt crisis in Hungary. Strong Chinese export data and domestic industrial output helped the market to pare losses posted early in the week. However, the negative closing on Monday and Tuesday caused the damage and both benchmarks-the Sensex and the Nifty-ended flat for the week.

The top weekly gainers on the Sensex were Cipla (up 4%), Mahindra & Mahindra, HDFC Bank, Reliance Communications (RCom) and BHEL (up 3% each). The top losers were DLF (down 7%), Hindalco Industries (down 6%), Infosys Technologies (down 4%), ITC and Tata Steel (down 3% each).

In the sectoral space on the BSE, auto surged 2% while healthcare gained 1% while realty tanked 4% and IT was down 3%.

The monsoon arrived in the early part of the week as per the prediction by the weather office in the previous week. For the week ended 2nd June, rainfall was at 16.7 millimetres, down 11.2% from the normal weekly rainfall of 18.8 millimetres.

Montek Singh Ahluwalia, deputy chairman of the Planning Commission said that fuel prices must be increased. Oil minister Murli Deora has made a strong pitch for raising fuel prices, saying it was needed to cut losses of State-run oil companies. The oil ministry is in favour of a gradual increase in fuel prices starting with a quick rise in petrol prices and gradual increase in diesel prices. The empowered group of ministers (EGoM) is likely to meet on 17th June to discuss fuel pricing reforms, as the meeting to be held earlier this week was deferred due to absence of key members.

The Bank of Japan has kept interest rates near zero and had outlined last month a new loan programme aimed at encouraging commercial banks to lend more to industries with growth potential. Japanese bank lending marked its biggest annual fall in nearly five years in May, as companies were reluctant to increase capital spending. Bank lending fell 2% in May from a year earlier, dropping for the sixth straight month and marking the biggest annual decline since July 2005.

The Reserve Bank of India (RBI) said that inflation is likely to ease with the monsoon; however, it is speculated that the central bank will tighten the monetary policy in its quarterly review next month. It has played down any concerns regarding food prices.

The International Monetary Fund (IMF) said that the euro crisis could affect global trade dampening demand for Asian exports and sending "hot money" into the region if policymakers fail to act swiftly and appropriately. The strong growth prospects in Asia were also likely to bring capital inflows into the region leading to an asset bubble.

Chinese exports in May grew about 50% from a year earlier. Consumer prices in May rose 3.1% from a year earlier, accelerating from 2.8% in April.

The Indian government has a cash balance of Rs480 billion with the RBI and will spend it gradually rather than in one go. It will expand liquidity support as banks are likely to need more cash ahead of the payment of advance tax and payment towards the broadband wireless access (BWA) spectrum fees.

Finance minister Pranab Mukherjee said that the target of direct tax receipts for the financial year 2010-11 is expected to exceed the target of Rs4.30 lakh crore.

The government has deferred its decision to announce the date of selling stake in two mining companies-Coal India and Hindustan Copper. It planned to sell about 10% stake in Coal India, the world's largest coal miner, through an initial public offering to raise roughly $2.7 billion. It also planned to sell about 20% stake in Hindustan Copper to raise up to about Rs50 billion ($1.06 billion).

The food price index rose 16.74% in the year to 29th May, higher than the previous week's annual reading of 16.55%, following a rise in prices of fruits and potato. The fuel price index climbed 14.23%, compared with an annual rise of 14.14% in the previous week.

Industrial output rose 17.6% in April from a year earlier, the strongest since December 2009, helped by buoyant domestic consumer demand, a revival in exports and higher infrastructure spending, data showed on Friday. Manufacturing production was up 19.4% over the year-ago period. Mining output was up 11.4% and power generation rose 6%. Car sales in India rose an annual 30% in May over the year-ago period. The finance minister termed the industrial output data as "encouraging."

Japan has indicated that it will raise taxes and warned on defaulting on its public borrowing. The government plans to compile a medium- and long-term plan for reining in debt by 22nd June at the latest and to limit the government bond issuance at 44.3 trillion yen ($484.6 billion) in the year to 31st March 2012.


Parabolic Drugs has a limited product category

The company derived 100% of its gross income (Rs374.52 crore) from the antibiotics category in the nine months ended December 2009

Chandigarh-based pharmaceutical company Parabolic Drugs Ltd (PDL) hits the primary market with its initial public offering (IPO) on 14 June 2010. The company has fixed the price band at Rs 75-Rs85 per share and plans to raise Rs200 crore through the issue.

The IPO has been assigned 'Grade 2' by ratings agency Brickwork, indicating 'below average' fundamentals. ICICI Securities Ltd and Spa Merchant Bankers Ltd are the lead book running managers to the issue. The issue closes on 17 June 2010.

Meanwhile, the BSE healthcare index has jumped 11% so far this year.
PDL derived 100% of its gross income (Rs374.52 crore) from the antibiotics category in the nine months ended December 2009 as it specialises in a limited number of therapeutic categories.

The company produces Semi Synthetic Penicillin (SSP) and Cephalosporin range of antibiotics in oral and sterile forms, along with their intermediates.

It had a cash flow of Rs4.42 crore for the nine months ended 31 December 2009. The company registered a net profit of Rs21.41 crore in the nine months ended December 2009 on a total income of Rs350.15 crore.

The company operates in a highly competitive environment especially in the Active Pharmaceutical Ingredient (API) product segment. Parabolic faces entry barriers as the research, testing, manufacturing, selling and marketing of pharmaceutical products are subject to extensive regulations, which differ from country to country.

The name and logo of 'Parabolic' are not registered trademarks of the company. A majority of its raw materials are imported from China. PDL imported 22.62% of its raw material from China in FY09. The company has filed 11 patent applications that are pending approval. The pharmaceutical industry is prone to patent and infringement risks.

The Director General of Foreign Trade (DGFT) and the ministry of commerce have demanded Rs2.17 crore from the company for non-fulfilment of certain export obligations. The company has made preferential allotments to various entities and promoters at different prices on the same date.

PDL will use the proceeds to set up a multi-purpose block III in Derabassi (Punjab), establishing a Sterile Cephalosporin plant at Derabassi, establishing of the Chachrauli plant (Haryana), and for investing in its subsidiary and repayment of loans. Its competitors like Neuland Laboratories and Dishman Pharma have EPS of Rs21.2 and Rs11.2 respectively. Parabolic's EPS has fallen from Rs12.70 in FY08 to Rs6.6 in FY09.




6 years ago

Invest only to lose money

k a prasanna

6 years ago

Poor quality IPO. There will not any listing gains. Stay away. For detailed analysis log on to FIRSTCHOICEIPOANALYSIS.COM

We are listening!

Solve the equation and enter in the Captcha field.

To continue

Sign Up or Sign In


To continue

Sign Up or Sign In



The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)